Manchester system brachytherapy simulation using EGSnrc Monte Carlo simulation

Shella Salsa Octavia, Tony Sumaryada, Sitti Yani

Abstract


One type of cervical cancer treatment is brachytherapy using the Manchester system. In this study, isodose curves were analyzed on tissue phantoms irradiated using several types of radioactive sources with the Manchester system using Monte Carlo simulation, EGSnrc. This study used a homogeneous tissue phantom with dimension 10 × 10 × 10 m3. The Manchester system uses 2 ovoid and 3 tandem containing radioactive sources placed inside the phantom. The resulting isodose curves were combined and analyzed using MATLAB-based VDOSE GUI. The results showed that the dose distribution for each type of radioactive source at the reference point had different values, namely Cobalt-60 had a dose distribution at reference point A of 15.08% with a dose distribution at reference point B of 0%, Cesium-137 was 13.37% and 0%, Iridium-192 was 13.27% and 0%. The use of radioactive source types can be adjusted to the actual location of cervical cancer.

Keywords


Brachytherapy; EGSnrc; isodose curve; Monte Carlo; Manchester system

Full Text:

PDF

References


1. Stish, B. J., Davis, B. J., Mynderse, L. A., McLaren, R. H., Deufel, C. L., & Choo, R. (2018). Low dose rate prostate brachytherapy. Transl Androl Urol, 7(3), 341–356.

2. Görkem, A. K. S. U. (2017). Serviks ve endometrium kanserinde brakiterapi. Turkish Journal of Oncology, 32(1), 34–35.

3. Wen, A., Wang, X., Wang, B., Yan, C., Luo, J., Wang, P. & Li, J. (2022). Comparative analysis of 60Co and 192Ir sources in high dose rate brachytherapy for cervical cancer. Cancers, 14, 749.

4. Hellman, K., Hellström, A. C., & Pettersson, B. F. (2014). Uterine cervix cancer treatment at Radiumhemmet: 90 years’ experience. Time trends of age, stage, and histopathology distribution. Cancer Med., 3(2), 284–292.

5. Strohmaier, S. & Zwierzchowski, G. (2011). Comparison of Co-60 and Ir-192 sources ih HDR brachytherapy. Journal of Contemporary Brachytherapy, 3(4), 199–208.

6. Carvalho, H.A. & Mauro, G.P. (1992). History of radiotherapy in the treatment of uterine cervix cancer: an overview. Rev Assoc Med Bras., 69(suppl 1), e2023S126.

7. Zhang, S., Xu, H., Zhang, L., & Qiao, Y. (2020). Cervical cancer: Epidemiology, risk factors and screening. Chin J Cancer Res., 32(6), 720–728.

8. Tod, M. & Meredith, W.J. (1953). Treatment of cancer of the cervix uteri, a revised Manchester method. Br J Radiol. 26, 252–257.

9. Hoskin, P. J. & Rembowska, A. (1998). Dosimetry rules for brachytherapy using high dose rate remote afterloading implants. Clinical Oncology. 10(4), 226–230.

10. Eng, T. Y., Cummins, S., & Baake, D. (2007). Point A or point H in prescribing high-dose-rate (HDR) intracavitary brachytherapy for cervical carcinoma? International Journal of Radiation Oncology, Biology, Physics. 69(3), S396–S397.

11. Kurniati, F., Krisna, F. P., Junios, & Haryanto F. (2021). The dose distribution from Iridium-192 source on cervical cancer brachytherapy by Manchester system using Monte Carlo simulation. Atom Indonesia. 47(3), 205–211

12. Morato, S., Juste, B., Peris, S., Miro, R., Verdu, G., Ballester, F., & Vijande, J. (2018). Brachytherapy organ dose estimation using Monte Carlo simulations of realistic patient models. Annu Int Conf IEEE Eng Med Biol Soc, 2018, 6149–6152.

13. Liu, J., Medhat, M. E., & Elsayed, A. M. M. (2024). Geant 4 Monte Carlo simulation for I-125 brachytherapy. Nuclear Engineering and Technology, 56(7), 2516–2523.

14. Walters, B., Kawrakow, I., & Rogers, D.W.O. (2021). DOSXYZnrc User Manual. Ottawa: National Research Council Canada.

15. Banahene, J. O., Darko, E. O., Abubakar, M., Awuah, B., & Amoako. (2019). Using Manchester system for the treatment of cervix carcinoma for a selected oncology facility in Ghana. International Journal of Science and Research (IJSR), 8(1), 1395–1401.

16. Toossi, M. T. B., Ghorbani, M., Makhdoumi, Y., Taheri, M., & Shandiz, F.H. (2012). A retrospective analysis of rectal and bladder dose for gynecological brachytherapy treatments with GZP6 HDR afterloading system. Reports of Practical Oncology & Radiotherapy, 17(6), 352–357.




DOI: http://dx.doi.org/10.31258/jkfi.21.3.281-288

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Indexing by:

  

 

Image